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Abstract The gastrointestinal tract of healthy individuals
is colonized by hundreds of saprophytes and mycetes,
especially the Candida species, are habitual ones. Under
certain conditions, the fungal flora may overgrow, resulting
in lesions of the digestive mucosa which, rarely, can have a
local diffusion and/or spread to the lympho-hematogenous
system. Mycotic infections of the stomach can sometimes
look like benign gastric ulcers. Here, we present the case
report of a woman, aged 64, who presented with type II
diabetes mellitus and psoriasis, on chronic treatment with
cyclosporin A and with endoscopic evidence of an ulcer-
ated, vegetating gastric lesion secondary to Candida albi-
cans infection. Although strongly suggestive of
malignancy, it completely healed after cyclosporin with-
drawal and the administration of oral antifungal drugs.
Keywords Candidiasis  Mycotic infection of the
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Introduction
The digestive tract is colonized by hundreds of saprophytes
including mycetes, especially the Candida species [1, 2].
Mycotic infections of the gastrointestinal system are rare
and usually involve the upper digestive tract. Nevertheless,
under certain conditions, fungal flora may overgrow,
resulting in lesions of the digestive mucosa, which can,
rarely, have a local diffusion and/or spread to the lympho-
hematogenous system. The most important risk factors are
the following: (1) the administration of antibiotics, ste-
roids, immunosuppressive and anticancer drugs; (2) gas-
trointestinal diseases, such as eosinophilic gastritis, cancer
(i.e., lymphoma), Zollinger-Ellison syndrome and Crohn’s
disease; (3) systemic diseases, such as tuberculosis and
polyarteritis nodosa; (4) smoking. Mycotic infections of the
stomach can sometimes look like benign gastric ulcers.
This relationship has been repeatedly reported in the lit-
erature, but never clearly demonstrated [3–6]. We report
the case of a woman, aged 64, who presented with type 2
diabetes mellitus (DM) and psoriasis, on chronic treatment
with an immunosuppressive drug such as cyclosporin A
and with endoscopic evidence of an ulcerated, vegetating
gastric lesion secondary to Candida (C.) albicans infection.
Although strongly suggestive of malignancy, the lesion
completely healed after cyclosporin withdrawal and the
administration of oral antifungal drugs.
Case report
In August 2010, a 64-year-old woman was admitted to our
Department for epigastric pain and melena. Furthermore,
she reported anorexia and a weight loss of 5 kg over the
previous 3 months. In 1990, she had been diagnosed with
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psoriasis and had been treated with cyclosporin A since
2003. She was also receiving metformin treatment for type
2 DM and acetylsalicylic acid (ASA) for a previous myo-
cardial ischemia. Clinical examination showed severe
epigastric pain, cutaneous pallor and psoriatic lesions
mostly localized to the sacrum and nails. Laboratory tests
showed hypochromic microcytic anemia (hemoglobin
concentration 8.3 g/dl; n.v. 12–17), with hyposideremia
(3 lg/ml; n.v. 40–200) and hypoferritinemia (7 ng/ml; n.v.
15–300). Endoscopic examination of the upper digestive
tract revealed a multi-ulcerated vegetating lesion greater
than 5 cm in size on the posterior wall of the stomach body,
which was affecting the progression of peristaltic waves
(Fig. 1). The ulcers showed irregular margins and fibrinous
bottoms. Although these findings were strong clinical evi-
dence of a malignant gastric lesion, biopsies of the ulcers and
of the vegetating lesion revealed only a marked chronic
inflammatory infiltrate with moderate activity, associated
with degenerative-necrotic phenomena. The patient was
therefore discharged, given proton pump inhibitors (PIPs)
and advised to undergo endoscopy and histology follow-up.
Three weeks later, the patient was re-admitted to our
Department and another endoscopy of the upper digestive
tract showed an unchanged ulcerated vegetating lesion on
the posterior wall of the stomach body. Multiple biopsies
showed chronic gastritis with generally moderate activity,
but locally severe, and areas of foveolar hyperplasia. CT
scan with contrast medium of the chest and abdomen
revealed a 7-mm nodular lesion in the medial segment of
the right middle lobe of the lung of unknown origin and
irregular thickening of the posterior wall of the stomach
body. This was associated with hyperplastic lymph nodes
along the lesser curvature of the stomach, in the liver hilum
and celiac, portacaval and inter-aorto-caval regions, as well
as splenomegaly (Fig. 2). The patient was discharged and
then admitted to the Surgery Department of our Hospital,
where a new upper digestive tract endoscopy showed evi-
dence of the same lesion which now extended to the
stomach body and antrum. At this time, however, biopsies
showed chronic gastritis, with moderate activity and
degenerative-necrotic phenomena, and a great quantity of
C. albicans hyphae in the inflammatory exudates (Fig. 3).
On this basis, cyclosporin was withdrawn and oral itraco-
nazole treatment commenced (100 mg b.i.d. for 15 days,
then repeated after 15 days of suspension). After 6 weeks,
the patient’s symptoms disappeared, body weight increased
by 3 kg and anemia improved (hemoglobin concentration
10.8 g/dl). Two months later, endoscopy showed a signif-
icant volume reduction in the vegetating and ulcerated
stomach lesion (Fig. 4), while CT scan with contrast
medium of the chest and abdomen showed the complete
disappearance of the gastric thickening, abdominal lymph
nodes and the nodular lung picture. Further upper digestive
tract endoscopy after 6 months revealed the complete dis-
appearance of the lesion.
Discussion
Even though mycetes are habitual saprophytes in healthy
subjects, candidiasis is the most frequent fungal infection of
the gastrointestinal canal. Candida has been described in
oropharynx, jejunum, ileum and stool samples [7]. Not only
immunocompromised patients may suffer from Candida
infections, but even apparently healthy subjects [8]. The
esophagus is the area most usually involved, and infection is
Fig. 1 Endoscopic appearance of a multi-ulcerated vegetating lesion,
with circumferential pattern, [5 cm in size, on the posterior wall of
the stomach body. Ulcers presented with irregular margins and
fibrinous bottoms
Fig. 2 CT scan of irregular thickening of the posterior wall of the
stomach body, associated with hyperplastic lymph nodes along the
lesser curvature of the stomach, liver hilum and celiac, portacaval and
inter-aorto-caval regions, as well as splenomegaly
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associated with odynophagia, dysphagia and bleeding. The
stomach, despite its extremely acid environment, may also
be affected, showing diffuse mucosal involvement or,
occasionally, a focal invasion and colonization of benign
gastric ulcers [9, 10].
Autopsy studies have shown an estimated prevalence of
fungal infection in the gastrointestinal tract of 4% in
deceased cancer patients. Prospective studies have dem-
onstrated an esophageal localization in 2.5–7.3% of
patients who had undergone endoscopy, as well as a fungal
infection in 16% of benign gastric ulcers and in 18% of
stomachs resected for gastric ulcers. These data suggested
that a benign gastric ulcer associated with an overlying
Candida infection is not uncommon [3, 7, 11, 12].
The high prevalence of gastrointestinal fungal infections
might be explained by a decreased immunological com-
petence and an increased incidence of systemic diseases
(especially DM and malignancies), as well as by the
increased use of anti-H2 receptors or PPIs which, by
altering the acid gastric environment, may promote over-
growth of the physiological mycotic flora [13–15]. The
stomach fundus is mainly affected by benign infection
gastric ulcers, perhaps because it is the most common site
for benign gastric ulcers. Endoscopy findings of Candida-
infection gastric ulcers vary from ulcerated lesions with
indented borders to submucosal tumor-like lesions, bezoar-
like images, gastric foreign bodies and very large lesions
([2 cm) [16–18].
There are few reported cases of bleeding or perforation
caused by Candida-infection gastric ulcers, and therapy
should be commenced as soon as possible [19–22]. Treat-
ment modalities include anti-H2 receptors/PPIs or anti-
fungal drugs, or a combination of both, but well-defined
guidelines have not yet been established. Antifungal
treatment seems to be unnecessary in young patients
without severe underlying diseases, since most of these
have been reported to recover without specific treatment.
Antifungal drugs may be considered either in high-risk
patients (advanced age, use of immunosuppressive drugs,
malignancy), where elevated fungal proliferation may
cause local complications (bleeding and/or perforation),
the systemic spreading of mycetes or colonized ulcers
Fig. 3 Histology of the gastric
lesion, showing chronic
gastritis, with moderate activity
and degenerative-necrotic
phenomena (hematoxylin and
eosin staining), and numerous
Candida albicans hyphae,
positive for Alcian Blue and
Periodic Acid-Schiff (PAS)
staining, in the inflammatory
exudate
Fig. 4 Endoscopic appearance of the significant volume reduction in
the vegetating ulcerated stomach lesion after 2 months of itraconazole
therapy
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unresponsive to treatment with anti-H2 receptors and PPIs
[23, 24].
To our knowledge, this is the first report of an ulcerated
vegetating gastric lesion strongly suggestive of malignancy,
in which Candida etiology was clearly proven by the failure
of the standard therapy with anti-H2 receptors and PPIs and
by the complete response to the antifungal therapy and the
suspension of the immunosuppressive drug. The infection, as
described in the literature, occurred in a high-risk adult
immunosuppressed patient with type 2 DM and on chronic
treatment with cyclosporin for psoriasis [3, 4].
Digestive mucosal immunity to C. albicans depends on
multiple immune components, i.e., CD4? and CD8? cells
and polymorphonuclear leukocytes (PMNs), and nonim-
mune cells, such as oral keratinocytes, epithelial cells and
stromal cells. However, both experimental and clinical data
are consistent with a central role for T cells in the host
response against gastrointestinal candidiasis, represented by
TH1 cytokine profile expression by CD4? cells (i.e., pro-
duction of IFN-c), without demonstrable TH2-like response.
Moreover, interactions between T cells and PMNs are
required to keep host defense to Candida infection running.
IL-17-mediated regulation of neutrophil expansion, recruit-
ment and migration allows TH17 cells, activated by
CD4? cells, to also modulate the PMNs response [25–27].
Patients affected with type 2 DM have more infections
than not affected ones. Course of infections is also more
complicated in the firsts. One of the possible causes of this
increased infections prevalence is a defect in immune
responses. Concerning adaptive immunity, it has been
demonstrated a TH2-axis shift, which reduces TH1-depen-
dent immunity. Other faults (e.g., low complement factor 4,
decreased cytokine response after stimulation) in humoral
innate immunity have been described in diabetic patients.
Regarding cellular innate immunity, most studies showed
decreased functions (chemotaxis, phagocytosis, killing) of
diabetic PMNs and monocytes/macrophages compared with
controls ones [28]. In addition, DM represents an important
contributory factor in digestive candidosis. Several patho-
genic mechanism have been hypotized to explain the higher
risk of digestive mucosal infection by Candida in DM
patients: high salivary glucose levels, which favor yeast
growth; glycosylation products with proteins on buccal
epithelial cells during hyperglycemic episodes, that may
increase the number of available receptors for Candida;
decrease in salivary flow rate, sometimes described in DM
patients, which may further enhance Candida colonization,
by reduction in immunoglobulin A and free secretory com-
ponent levels, which normally inhibit Candida; and finally,
decreased phagocytosis, intracellular killing, bactericidal
activity and chemotaxis of PMNs, associated, particularly,
with poorly controlled diabetes, that may render the diabetic
patients more susceptible to Candida infection [29].
Cyclosporin A effectively suppresses T-cell-dependent
immune reactions, binding together with cyclophilin, a
cytoplasmic receptor protein present in T lymphocytes, and
this complex further hitches to calcineurin and inhibits
Ca2?-stimulated dephosphorylation of the cytoplasmic
component of the nuclear factor of activated T cells
(NFAT), thus inhibiting translocation of NFAT from
cytoplasm to nucleus of activated T cells, and therefore, T
cells function. Considering the role of CD4? and CD8? T
cells in the development of an effective immune response
to mycetes, i.e., Candida, it is possible that impairing of
adaptive immunity may be co-responsible for Candida
overgrowth and the histopathologic findings of our high-
risk patient for fungal infections [30, 31]. The malignant
tumor-like characteristics of the lesion may be due to
inflammation and cell infiltration in the deep mucosal
layer, which completely healed after antifungal treatment,
as did the hemorrhagic complication of the lesion (iron
deficiency and sideropenic anemia) and its loco-regional
(circumferential gastric wall involvement plus abdominal
lymph node colonization) and probably systemic (pul-
monary) diffusion.
In conclusion, this case report suggests that in a high-
risk patient for fungal infections a benign gastric lesion,
albeit with malignant tumor-like characteristics, may
indicate the possibility of Candida infection and conse-
quent specific antifungal treatment.
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